Oxford Biodynamics PLCLSE Oxford Biodynamics Stock Report

Oxford BioDynamics Plc is a biotechnology company, which engages in the discovery and development of novel epigenetic biomarkers for use within the pharmaceutical and biotechnology industry. The firm is advancing personalized healthcare by developing and commercializing precision medicine tests for diseases, based on the Company’s three-dimensional (3D) genomics platform, EpiSwitch. EpiSwitch research and medical analysis services focus on the discovery, evaluation, validation and monitoring of epigenetic biomarker known as chromosome conformation signatures (CCSs) for use in medical testing kits, disease prediction, diagnosis and treatment. The Company’s products include EpiSwitch Checkpoint Inhibitor Response Test (CiRT), EpiSwitch Covid-19 Severity Test (CST), EpiSwitch Explorer Array Kit, EpiSwitch Analytical Portal and EpiSwitch Service. EpiSwitch CiRT provides patient specific guidance. EpiSwitch CST delivers essential information based on genetic markers to aid in determining an individual’s risk of severe immune response requiring critical care due to COVID-19.